Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for bruxism and temporomandibular joint pain
RBR-6jhqzdPhase 3Completed
- Sponsor
- Universidade Federal de Uberlândia
- Start
- Dec 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of botulinum toxin type A in bruxism and temporomandibular disorder (TMD) (2 arms), sponsored by Universidade Federal de Uberlândia. Started Dec 2017; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
bruxismtemporomandibular disorder (TMD)
Beyond the preview
Go deeper on RBR-6jhqzd.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6jhqzd.